Evidence map›Paper›PMID 41121225›Full record

ReviewBMC biology2025

TCA-cycle metabolites in the nucleus: drivers of chromatin and epigenetic control.

Serena Ghisletti, Marta Russo

Abstract readReview
In one paragraph

Review in BMC biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Serena Ghisletti *Department of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan, Italy. serena.ghisletti@unimi.it.
Marta Russo *Biomedical Center (BMC), Division of Physiological Chemistry, Faculty of Medicine, LMU Munich, Munich, Germany. marta.russo@lmu.de.

Funding

Deutsche Forschungsgemeinschaft RU 2836/1-1Fondazione AIRC per la ricerca sul cancro ETS 24506
6 · The paper itself

Abstract

Mitochondrial enzymes are increasingly recognized for their ability to translocate to the nucleus, where they generate metabolites essential for epigenetic regulation and gene expression. Yet, whether this phenomenon broadly involves metabolic enzymes or is restricted to specific subunits remains unclear. In this review, we assess current evidence, highlight knowledge gaps, and suggest future directions on the nuclear localization and functions of metabolic enzymes, with a focus on acyl-CoA producers. Emerging studies reveal multiple mechanisms guiding these enzymes to chromatin for localized metabolite synthesis. Key questions concern nuclear import machinery, chromatin interactions, and the regulatory impact of their activity.

Indexed as

Cell NucleusChromatinCitric Acid CycleEpigenesis, GeneticAnimalsHumansChromatinHistone modificationsMetabolismMitochondrial enzymesTranscriptional regulation

Identifiers

PMID41121225
PMCPMC12542002

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.